PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK – Trademark Portfolio
Entity Type: 99
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include G&M.
BARIS MAH. DR.ZEKI ACAR CAD. TÜBITAK 1 17,
Gebze Kocaeli
Showing of trademarks Trademarks
Trademark Classifications
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK have?
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK file in?
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK's most well-known trademarks?
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK's registered trademark portfolio includes well-known marks such as G&M. These are among 1 currently registered trademark in the portfolio.
What is PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK's trademark registration success rate?
PHI TECH BILISIM BIYOTEKNOLOJI DANISMANLIK has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.